Dr. Aaron T. Bowman, MD
Hematology & Oncology (Hematology & Oncology Physician)
Who else practices at this address →
Washoe County includes primary care (2% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Ohio State University College of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 721
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Ohio State University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
NV license 12719 -
Internal Medicine Physician
UT license 5765345-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Renown Regional Medical Center Reno, NV
- Renown South Meadows Medical Center Reno, NV
- Northern Nevada Medical Center Sparks, NV
- Banner Churchill Community Hospital Fallon, NV
- Humboldt General Hospital Winnemucca, NV
Medical groups
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 721
- Services billed
- 123,943
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 2,700 | 13 |
| Established patient office or other outpatient visit, 30-39 minutes | 503 | 196 |
| Injection, dexamethasone sodium phosphate, 1 mg | 470 | 23 |
| Injection, palonosetron hcl, 25 mcg | 390 | 20 |
| Established patient office or other outpatient visit, 40-54 minutes | 219 | 99 |
| Insertion of needle into vein for collection of blood sample | 166 | 106 |
| Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 156 | 11 |
| Established patient office or other outpatient visit, 20-29 minutes | 150 | 101 |
| Injection of additional new drug or substance into vein | 147 | 26 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 146 | 98 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Reno, NV | 94 |
| Acyclovir Other prescribers in Reno, NV | 75 |
| Allopurinol Other prescribers in Reno, NV | 54 |
| Potassium Chloride Other prescribers in Reno, NV | 48 |
| Hydroxyurea Other prescribers in Reno, NV | 48 |
| Letrozole Other prescribers in Reno, NV | 46 |
| Gabapentin Other prescribers in Reno, NV | 40 |
| Eliquis (apixaban) Other prescribers in Reno, NV | 38 |
| Diphenhydramine Hcl | 35 |
| Imbruvica (ibrutinib) | 32 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 21 payments worth $549 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $98.87 |
|---|---|
| Novartis Pharmaceuticals Corporation | $55.58 |
| AstraZeneca Pharmaceuticals LP | $43.25 |
| Pfizer Inc. | $40.69 |
| Springworks Therapeutics, Inc. | $31.52 |
| Array Biopharma Inc | $30.17 |
| Janssen Biotech, Inc. | $30.14 |
| Astellas Pharma US Inc | $29.92 |
| Food and Beverage | $492 |
|---|---|
| Education | $57.18 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 19, 2025 | Education ENHERTU · Oncology · in-kind Company’s descriptionJournal Article | $43.25 |
| Acrotech Biopharma Inc. Dec 23, 2025 | Education BELEODAQ · ONCOLOGY · in-kind | $13.93 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.